Dynasty Ceramic Public Company Limited (DCC)
SET SET Primary Summary
DCC Chart
Dynasty Ceramic Public Company Limited (DCC) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Dynasty Ceramic Public Company Limited ever had a stock split?
Dynasty Ceramic Public Company Limited Profile
| Professional Services Industry | Industrials Sector | - CEO | SET Exchange | TH0278A10Z08 ISIN |
| Indonesia Country | 91 Employees | 18 May 2026 Last Dividend | 7 Jan 2015 Last Split | - IPO Date |
Overview
PT Diagnos Laboratorium Utama Tbk is a prominent healthcare provider operating from Jakarta Pusat, Indonesia, specializing in a wide array of laboratory-based health services. Since its inception in 2007, the company has been at the forefront of delivering comprehensive clinical pathology and genomics laboratory tests across Indonesia. Catering to a diverse clientele, PT Diagnos Laboratorium Utama Tbk is dedicated to enhancing healthcare outcomes through its state-of-the-art laboratory services, including a focus on reproductive health, oncology, and infectious diseases among others. Its commitment to utilizing advanced technology and specialized expertise underscores its mission to provide accurate and timely health diagnostics.
Products and Services
- Clinical Pathology Laboratory Tests
Includes a broad spectrum of tests such as hematology, hemostasis, clinical chemistry, urinalysis, biomolecular, immunology, microbiology, and anatomical pathology. These tests are pivotal for diagnosing diseases, monitoring health conditions, and guiding treatment decisions.
- Genomics Laboratory Tests
Offers cutting-edge genetic testing services catering to reproductive health, pregnant women, and couples wishing to conceive. This segment also includes oncology tests, drug sensitivity, DNAandMe, among other personalized medicine services. These tests provide insights into genetic disorders, cancer genetics, and personalized medication strategies.
- Homecare Health Services
Provides convenient at-home health services for tests like hemoglobin, ferritin, retilulosit, hematologi rutin, SARS-COV-2 omicron screening molecular test, and PCR SARS-COV-2 H+1 B2C. This service is tailored for individuals requiring professional medical tests from the comfort of their homes.
- SARS-CoV-2 Screening Services
Specializes in screening services for SARS-CoV-2, including both omicron variant screening and general PCR testing. This service is crucial for early detection and management of COVID-19, aiding in the control of the pandemic's spread.
